RSV is the leading cause of hospitalization in infants and one of the main drivers of child mortality
Nirsevimab can protect babies throughout the duration of a virus season
Nirsevimab is not a vaccine. It’s a preventive drug that offers passive immunity.
Prevention is essential because RSV-specific treatments don’t exist
RSV season is around the corner, so parents should check with their child’s pediatrician about nirsevimab.
Source: Read Full Article